Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.400
0.00 (0.00%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Envoy Medical Stock Forecast
COCH's stock price has decreased by -71.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 9.13, with a low estimate of 9.00 and a high estimate of 9.25. The average target predicts an increase of 552.14% from the current stock price of 1.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Envoy Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $9.25 | Strong Buy | Maintains | $9 → $9.25 | +560.71% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.75 → $9 | Strong Buy | Maintains | $8.75 → $9 | +542.86% | Dec 6, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +542.86% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +525.00% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +507.14% | Jun 24, 2024 |
Financial Forecast
Revenue This Year
306.00K
from 225.00K
Increased by 36.00%
Revenue Next Year
357.00K
from 306.00K
Increased by 16.67%
EPS This Year
-1.29
from -1.49
EPS Next Year
-1.58
from -1.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 420,000 | 420,000 |
| Avg | 306,000 | 357,000 |
| Low | 196,000 | 294,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 86.7% | 37.3% |
| Avg | 36.0% | 16.7% |
| Low | -12.9% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.21 | -1.63 |
| Avg | -1.29 | -1.58 |
| Low | -1.46 | -1.52 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.